Reason for request
Renewal of inclusion on the list of medicines refundable by National Health Insurance and Re-assessment of the actual benefit following the Transparency Committee conclusions in its opinions of 26 November 2008 and reiterated in its opinion of 21 September 2011.
Clinical Benefit
| Insufficient |
The actual benefit of CHONDROSULF 400 mg capsules and granules is insufficient to justify reimbursement by National Insurance. |
eNq1mE1z2jAQhu/8Co8PvWHHIaTQ2mRamrTMJFOahGmnF0bY6yAqJEcffOTXV8akIR25aQQ62pLfXWlXj95xfLaaE28BXGBGEz8KjnwPaMoyTO8Sf3R70ez4Z71GPEML9DTtWM8Losj3UoKESPxyNJgAoiL4cXX5CfT3wP1ew4vZZAapfDZPSUyCL0hMr1BRzvHiBcOZNwc5ZVniF0pu3nqxkFxn0Vsy/ksUKIU43L7ZHZ2NT3bfx2Ep9h+qSgC/RPTOKArUSjNVnAOVfSThjvF1Tb4tK20srkEwxVMYIjkdcrbAGWTGEDkiAqyC5MvsBviCgCyDGMXDWToXVuJohlbXcD8wJ/1Bj/blSjaPmtHbTrfVaUft1kk3sgrFd7bKXAW9iDAdR632adTqhkDDdMpoxplQJLesz5BxiYijymDRf95cjuJwuH+xAzIsCoLWwUwUtluFONLDwDUC3C2kXMEt11Aies/+0qeKkPCVWY+2yHCUcUmkPlNU1pBjdGO7EX1GJazqK2oHO7na9iIGcTjZB0bNoB+qCcGpLdY0eBQIOboe1FPt0ED4iASMuDsifMc0Y0txeNLsVtZR9sUGlkbRgmfR+LjbOY3abeuD9FO3Uc1Nc644KyDUDMJiH7QMaM72hYruTLPUY18etCU3noeliECN62laMkb34qNJc9bt7k5SNWAU/Xx+a9si3xTw9c3m0SiNs+RPce0A7ILquiFfSrw6ukkxbh21tVE7eYPmxftHO51YWudK1IlzVtzMmamUhXgXhsvlMpgi0RRI72eQ83/fBWfG5R9iCzR4nyrqzuA7MQOVOaqg6yj1SXWbvq6Utof3JbuwrwXefr+12sYYkivYoxYV553ReHB+eMA/+V9naQ+fYcZdmI1XRRIz6so/qYlRcb8rRdeVXnANiK95jmt+uNT2ZRxWP3t6jTgsf/T0Gr8BM/oHZA==
t1m7jXqWDp1ST0DM
